Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 5.89% to $11.02 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.56% to 10,569.29 and the Dow Jones Industrial Average rising 2.13% to 33,630.61. The stock's fall snapped a two-day winning streak. Novavax Inc. closed $126.64 short of its 52-week high ($137.66), which the company achieved on January 10th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 0.81% to $180.25, Pfizer Inc. (PFE) rose 2.54% to $50.92, and Merck & Co. Inc. (MRK) rose 1.06% to $114.84. Trading volume (6.4 M) remained 72,785 below its 50-day average volume of 6.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 6, 2023.
(END) Dow Jones Newswires
January 06, 2023 17:15 ET (22:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.